AIH vs. CDIO, PLAG, TLIS, VINC, FLGC, TRAW, PMD, PPBT, KPRX, and MIRA
Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include Cardio Diagnostics (CDIO), Planet Green (PLAG), Talis Biomedical (TLIS), Vincerx Pharma (VINC), Flora Growth (FLGC), Traws Pharma (TRAW), Psychemedics (PMD), Purple Biotech (PPBT), Kiora Pharmaceuticals (KPRX), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "medical" sector.
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.
Cardio Diagnostics has a consensus target price of $1.35, suggesting a potential upside of 92.86%. Given Cardio Diagnostics' higher probable upside, analysts clearly believe Cardio Diagnostics is more favorable than Aesthetic Medical International Holdings Group.
2.1% of Aesthetic Medical International Holdings Group shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 55.1% of Aesthetic Medical International Holdings Group shares are owned by company insiders. Comparatively, 30.0% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -34,911.87%. Aesthetic Medical International Holdings Group's return on equity of 0.00% beat Cardio Diagnostics' return on equity.
Cardio Diagnostics received 1 more outperform votes than Aesthetic Medical International Holdings Group when rated by MarketBeat users. Likewise, 66.67% of users gave Cardio Diagnostics an outperform vote while only 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote.
Aesthetic Medical International Holdings Group has a beta of -0.21, suggesting that its stock price is 121% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 5.3, suggesting that its stock price is 430% more volatile than the S&P 500.
Aesthetic Medical International Holdings Group has higher revenue and earnings than Cardio Diagnostics.
In the previous week, Cardio Diagnostics had 1 more articles in the media than Aesthetic Medical International Holdings Group. MarketBeat recorded 3 mentions for Cardio Diagnostics and 2 mentions for Aesthetic Medical International Holdings Group. Aesthetic Medical International Holdings Group's average media sentiment score of 1.25 beat Cardio Diagnostics' score of 1.16 indicating that Aesthetic Medical International Holdings Group is being referred to more favorably in the media.
Summary
Cardio Diagnostics beats Aesthetic Medical International Holdings Group on 8 of the 15 factors compared between the two stocks.
Get Aesthetic Medical International Holdings Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aesthetic Medical International Holdings Group Competitors List
Related Companies and Tools
